Arsenite increases vasoconstrictor reactivity in rat blood vessels: Role of endothelial nitric oxide function

International Journal of Toxicology

Volumn 25, Issue 4, 2006, Pages 303-310

  Bilszta, Justin ^a   Dusting, Gregory ^a   Jiang, Fan ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Bernard O'Brien Institute of Microsurgery   (Australia)

Author keywords

Arsenite; Endothelium; Nitric Oxide; Phenylephrine; Rat; Vasoreactivity

Indexed keywords

ACETYLCHOLINE; ARSENIC TRIOXIDE; ARSENITE SODIUM; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; HEAT SHOCK PROTEIN 32; HEAT SHOCK PROTEIN 72; HEAT SHOCK PROTEIN 90; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RAT; RENAL ARTERY; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; ARSENITES; ENDOTHELIUM, VASCULAR; ENVIRONMENTAL POLLUTANTS; GENE EXPRESSION; HEAT-SHOCK PROTEINS; INJECTIONS, INTRAVENOUS; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE TYPE III; PHENYLEPHRINE; RATS; RATS, INBRED WKY; RENAL ARTERY; RNA, MESSENGER; VASOCONSTRICTION;

ANIMALIA;

EID: 33745872223     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810600746130     Document Type: Article

References (32)

1. Barchowsky, A., L. R. Klei, E. J. Dudek, H. M. Swartz, and P. E. James. 1999a. Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite. Free Radic. Biol. Med. 27:1405-1412.
2. Barchowsky, A., R. R. Roussel, L. R. Klei, P. E. James, N. Ganju, K. R. Smith, and E. J. Dudek. 1999b. Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways. Toxicol. Appl. Pharmacol. 159:65-75.
3. Bellmann, K., V. Burkart, J. Bruckhoff, H. Kolb, and J. Landry. 2000. p38-dependent enhancement of cytokine-induced nitric-oxide synthase gene expression by heat shock protein 70. J. Biol. Chem. 275:18172-18179.
4. Benjamin, I. J., and D. R. McMillan. 1998. Stress (heat shock) proteins: Molecular chaperones in cardiovascular biology and disease. Circ. Res. 83:117-132.
5. Bunderson, M., J. D. Coffin, and H. D. Beall. 2002. Arsenic induces peroxynitrite generation and cyclooxygenase-2 protein expression in aortic endothelial cells: Possible role in atherosclerosis. Toxicol. Appl. Pharmacol. 184:11-18.
6. Caudill, T. K., T. C. Resta, N. L. Kanagy, and B. R. Walker. 1998. Role of endothelial carbon monoxide in attenuated vasoreactivity following chronic hypoxia. Am. J. Physiol. 275:R1025-R1030.
7. Chen, C. J., Y. M. Hsueh, M. S. Lai, M. P. Shyu, S. Y. Chen, M. M. Wu, T. L. Kuo, and T. Y. Tai. 1995. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 25:53-60.
8. Chiou, H. Y., W. I. Huang, C. L. Su, S. F. Chang, Y. H. Hsu, and C. J. Chen. 1997. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke 28:1717-1723.
9. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
10. Docherty, J. R. 1998. Subtypes of functional alpha1- and alpha2-adrenoceptors. Eur. J. Pharmacol. 361:1-15.
11. Elia, G., and M. G. Santoro. 1994. Regulation of heat shock protein synthesis by quercetin in human erythroleukaemia cells. Biochem. J. 300:201-209.
12. Engel, R. R., and A. H. Smith. 1994. Arsenic in drinking water and mortality from vascular disease: An ecologic analysis in 30 counties in the United States. Arch. Environ. Health 49:418-427.
13. Garcia-Cardena, G., R. Fan, V. Shah, R. Sorrentino, G. Cirino, A. Papapetropoulos, and W. C. Sessa. 1998. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 392:821-824.
14. Griendling, K. K., D. Sorescu, and M. Ushio-Fukai. 2000. NAD(P)H oxidase: Role in cardiovascular biology and disease. Circ. Res. 86:494-501.
15. Hauser, G. J., E. K. Dayao, K. Wasserloos, B. R. Pitt, and H. R. Wong. 1996. HSP induction inhibits iNOS mRNA expression and attenuates hypotension in endotoxin-challenged rats. Am. J. Physiol. 271:H2529-H2535.
16. Hosokawa, N., K. Hirayoshi, A. Nakai, Y. Hosokawa, N. Marui, M. Yoshida, T. Sakai, H. Nishino, A. Aoike, K. Kawai, et al. 1990. Flavonoids inhibit the expression of heat shock proteins. Cell Struct. Funct. 15:393-401.
17. Jaattela, M. 1999. Heat shock proteins as cellular lifeguards. Ann. Med. 31:261-271.
18. Jiang, F., and G. J. Dusting. 2001. Endothelium-dependent vasorelaxation independent of nitric oxide and K(+) release in isolated renal arteries of rats. Br. J. Pharmacol. 132:1558-1564.
19. Jiang, F., G. R. Drummond, and G. J. Dusting. 2004. Suppression of oxidative stress in the endothelium and vascular wall. Endothelium 11:79-88.
20. Knoepp, L., A. Beall, D. Woodrum, J. S. Mondy, E. Shaver, M. Dickinson, and C. M. Brophy. 2000. Cellular stress inhibits vascular smooth muscle relaxation. J. Vasc. Surg. 31:343-353.
21. Koishi, M., N. Hosokawa, M. Sato, A. Nakai, K. Hirayoshi, M. Hiraoka, M. Abe, and K. Nagata. 1992. Quercetin, an inhibitor of heat shock protein synthesis, inhibits the acquisition of thermotolerance in a human colon carcinoma cell line. Jpn. J. Cancer Res. 83:1216-1222.
22. Lee, M. Y. O. N. Bae, S. M. Chung, K. T. Kang, J. Y. Lee, and J. H. Chung. 2002. Enhancement of platelet aggregation and thrombus formation by arsenic in drinking water: A contributing factor to cardiovascular disease. Toxicol. Appl. Pharmacol. 179:83-88.
23. Lee, M. Y., B. I. Jung, S. M. Chung, O. N. Bae, J. Y. Lee, J. D. Park, J. S. Yang, H. Lee, and J. H. Chung. 2003. Arsenic-induced dysfunction in relaxation of blood vessels. Environ. Health Perspect. 111:513-517.
24. Lynn, S., J. R. Gurr, H. T. Lai, and K. Y. Jan. 2000. NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ. Res. 86:514-519.
25. Moncada, S., R. M. Palmer, and E. A. Higgs. 1991. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
26. Pi, J., S. Horiguchi, Y. Sun, M. Nikaido, N. Shimojo, T. Hayashi, H. Yamauchi, K. Itoh, M. Yamamoto, G. Sun, M. P. Waalkes, and Y. Kumagai. 2003. A potential mechanism for the impairment of nitric oxide formation caused by prolonged oral exposure to arsenate in rabbits. Free Radic. Biol. Med. 35:102-113.
27. Simeonova, P. P., T. Hulderman, D. Harki, and M. I. Luster. 2003. Arsenic exposure accelerates atherogenesis in apolipoprotein E(-/-) mice. Environ. Health Perspect. 111:1744-1748.
28. Smith, K. R., L. R. Klei, and A. Barchowsky. 2001. Arsenite stimulates plasma membrane NADPH oxidase in vascular endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 280:L442-449.
29. Tsai, S. H., Y. C. Liang, L. Chen, F. M. Ho, M. S. Hsieh, and J. K. Lin. 2002. Arsenite stimulates cyclooxygenase-2 expression through activating IkappaB kinase and nuclear factor kappaB in primary and ECV304 endothelial cells. J. Cell Biochem. 84:750-758.
30. Vanhoutte, P. M. 2004. Endothelium-dependent hyperpolarizations: The history. Pharmacol. Res. 49:503-508.
31. Wang, C. H., J. S. Jeng, P. K. Yip, C. L. Chen, L. I. Hsu, Y. M. Hsueh, H. Y. Chiou, M. M. Wu, and C. J. Chen. 2002. Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation 105:1804-1809.
32. Yeh, J. Y. L. C. Cheng, Y. C. Liang, and B. R. Ou. 2003. Modulation of the arsenic effects on cytotoxicity, viability, and cell cycle in porcine endothelial cells by selenium. Endothelium 10:127-139.